Related Experiment Video
Updated: May 22, 2026
06:32
Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment
Published on: August 18, 2023
[Biomarkers for cancer immunotherapy]
Yutaka Kawakami1, Yoshie Kawase, Azusa Ohizumi
1Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 25, 2012
Summary
Immune biomarkers and assays are crucial for cancer immunotherapy, aiding patient selection, monitoring immune responses, and evaluating treatment effectiveness. These tools are vital for predicting and tracking therapeutic outcomes in oncology.
Area of Science:
- Oncology
- Immunology
- Biomarker Discovery
Context:
- Cancer immunotherapy development relies heavily on immune biomarkers and assays.
- Accurate patient selection and monitoring are essential for successful immunotherapy.
- Tumor microenvironment immune conditions require comprehensive evaluation.
Purpose:
- To highlight the importance of immune biomarkers and assays in cancer immunotherapy.
- To emphasize the need for comprehensive immune evaluation and blood biomarker identification.
- To underscore the potential utility of immunological biomarkers across various cancer treatments.
Summary:
- Immune biomarkers and assays are critical for selecting patients likely to respond to cancer immunotherapy, monitoring immune responses, and assessing anti-tumor effects.
- Comprehensive immune evaluation, including both positive and negative responses against cancer cells and blood biomarkers reflecting the tumor microenvironment, is necessary.
- The significance of immune responses is increasingly recognized in standard cancer treatments like chemotherapy and molecular targeted therapy, suggesting broad applicability for immunological biomarkers.
Impact:
- Advances the field of cancer immunotherapy by providing tools for personalized treatment strategies.
- Enables earlier and more accurate prediction of treatment response and efficacy.
- Broadens the application of immunological biomarkers beyond immunotherapy to other cancer treatment modalities.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...